08 August 2020>: Clinical Research
Protective Effect of Probiotics against Esophagogastric Variceal Rebleeding in Patients with Liver Cirrhosis after Endoscopic Therapy
Qun Zhang 1CDE , Fangyuan Gao 1CD , Xue Yang 1D , Ying Hu 1D , Yao Liu 1CD , Yixin Hou 1D , Yuxin Li 1D , Bingbing Zhu 2B , Shuaishuai Niu 1BF , Yunyi Huang 3B , Xianbo Wang 1ADG*DOI: 10.12659/MSM.924040
Med Sci Monit 2020; 26:e924040
Supplementary Table 2 Detailed etiological distribution.
Etiology | N (%) | Rebleeding rate | |
---|---|---|---|
Chronic HBV infection | 344 (48.9) | 42.7% | |
Chronic HCV infection | 63 (8.9) | 54.0% | |
Alcohol | 130 (18.5) | 60.0% | |
Alcohol+HBV | 53 (7.5) | 67.9% | |
Other HBV irrelevant | Alcohol+HCV | 9 (1.3) | 52.3% |
Alcohol+PBC+AIH | 1 (0.1) | ||
Alcohol+PBC | 3 (0.4) | ||
PBC+AIH | 4 (0.6) | ||
PBC | 28 (4.0) | ||
AIH | 7 (1.0) | ||
Unknown | 57 (8.1) | ||
Other HBV correlation | HBV+HCV | 3 (0.4) | 80.0% |
HBV+PBC | 2 (0.3) | ||
HBV – hepatitis B virus; HCV – hepatitis C virus; PBC – primary biliary cirrhosis; AIH – autoimmune hepatitis. |